Last updated: July 14, 2026
The table below maps each major device category to its primary transmitted data fields. Rhythm360 normalizes every stream into a single dashboard via API, HL7, XML, and AI-powered computer vision (OCR) for unstructured PDF parsing.
| Device Category | Representative OEMs | Key Transmitted Data Fields | Rhythm360 Ingestion |
|---|---|---|---|
| Pacemaker | Medtronic, Boston Scientific, Abbott, Biotronik | Battery status / RRT, lead impedance, pacing thresholds, arrhythmia episodes, transmission logs | Normalized via API, HL7, XML, and computer-vision PDF parsing; >99.9% transmissibility |
| ICD | Medtronic, Boston Scientific, Abbott, Biotronik | Shock history, ATP therapy, lead integrity, ventricular arrhythmia burden, device diagnostics | Redundant data feeds ensure continuity if an OEM server is unavailable; AI triage prioritizes critical alerts |
| CRT / CCM Device | Medtronic, Boston Scientific, Abbott, Biotronik | Biventricular pacing percentage, LV-LV delay, HF fluid index, OptiVol / HeartLogic scores, arrhythmia burden | Consolidated HF metrics displayed alongside rhythm data in a unified dashboard |
| Implantable Loop Recorder (ILR / ICM) | Medtronic LINQ, Abbott Confirm Rx, Biotronik BioMonitor | AF burden, pause detection, R-R intervals, cryptogenic-stroke follow-up data, monthly rhythm summaries | AI prioritization flags clinically significant episodes; monthly ICM transmissions auto-documented for CPT 93299 |
| CardioMEMS PA Sensor | Abbott CardioMEMS HF System | Daily pulmonary artery pressure (systolic, diastolic, mean), heart rate | PA pressure trends displayed alongside CIED data for unified HF population management |
Pacemakers from Medtronic, Boston Scientific, Abbott, and Biotronik all support wireless remote interrogation. The 2015 HRS Expert Consensus Statement confirms that CIEDs with wireless capabilities can monitor their own function, record arrhythmias and physiological parameters, and communicate this information to providers without active patient participation. The 2026 HRS/AHA/APHRS/EHRA/IDSA/LAHRS/PACES/STS consensus update calls for mandatory remote monitoring of pacemakers to catch lead failure and abnormal CIED performance before symptoms appear.
Scheduled transmission frequency for pacemakers is shaped by CMS reimbursement rules, which is why periodic transmissions are standard for therapeutic devices like pacemakers. Biotronik's Home Monitoring system goes further, performing daily transmissions for any actively enrolled patient.
Rhythm360 ingests pacemaker data from all major OEMs and delivers:
ICDs transmit a richer dataset than pacemakers because they must document every therapy delivery. Patients with ICDs want feedback on ventricular arrhythmias, device function, lead integrity, and battery life. Many ICD and pacemaker patients report a sense of security from remote monitoring, but that security only holds if care teams can consistently review the data these devices generate.
Rhythm360 makes that consistency possible by normalizing ICD transmissions from Medtronic, Boston Scientific, Abbott, and Biotronik into a single record, delivering:
CRT devices add biventricular pacing and heart failure diagnostics to the standard ICD data set. A multicenter pre-post study using the HeartLogic algorithm in heart failure patients with CIEDs observed fewer HF hospitalizations and shorter hospital stays after algorithm activation. EN ISO/IEEE 11073-10103:2025 adds standardized nomenclature for CRT multisite pacing status, LV-LV delay, and LV multisite pacing settings, giving vendors a common language for cross-vendor data transfer.
Rhythm360 consolidates CRT and CCM device data for proactive HF management, including:
ILRs and insertable cardiac monitors (ICMs) are built for long-term arrhythmia surveillance. They can detect atrial fibrillation that produces no symptoms, which matters most in cryptogenic stroke cases where the cause is otherwise unknown. Deep-learning algorithms integrated with these devices push detection accuracy higher while cutting the false-positive alerts that used to overwhelm clinic staff.
ICMs such as the Medtronic LINQ and Abbott Confirm Rx transmit heart rhythm data focused on arrhythmia detection, and automated inference of AF frequency, duration, and burden is reasonable using ILR/ICM data transmitted through remote monitoring platforms. The overall ILR market is projected to grow at 8.94% CAGR from 2026 to 2031, though no specific figure is reported for the remote monitoring segment alone.
Rhythm360 processes ILR transmissions with the same AI prioritization noted earlier, covering:
The CardioMEMS HF System and Cordella PA Pressure Sensor System sit in a different category: implanted hemodynamic sensors, not rhythm devices. The CardioMEMS HF System transmits pulmonary artery pressure and heart rate wirelessly from an implanted sensor to clinical staff for remote heart failure management, with FDA approval expanded in February 2022 to include NYHA Class II heart failure patients.
Rhythm360 ingests daily CardioMEMS transmissions and displays them alongside CIED data in one dashboard, letting clinicians correlate:
Each new vendor in cardiovascular remote monitoring introduces its own login and workflow, which worsens system fragmentation across pacemakers, ICDs, loop recorders, and wearables. The 2023 HRS/EHRA/APHRS/LAHRS consensus statement acknowledges that rising remote monitoring enrollment strains device clinic staff managing higher transmission volumes.
Fragmented data forces clinics to rely on effort, memory, and local workarounds, which makes the service hard to scale. Cardiovascular programs lose revenue from gaps in engagement, not billing errors. When staff fail to pull data or confirm patient transmissions, they lose clinical visibility and the ability to bill for the service.
Rhythm360 closes these gaps through:
Practices implementing Rhythm360 have achieved the 300% CPT revenue increase mentioned earlier, driven by better code capture and staff efficiency.
Full onboarding with EHR integration typically takes days to weeks, not months. Rhythm360's implementation team minimizes disruption to existing clinical workflows, offering dedicated support through device connectivity setup, staff training, and go-live validation.
Once live, that same infrastructure extends to mobile devices, so on-call staff get the same speed and visibility in the field.
Rhythm360's HIPAA-compliant mobile app lets electrophysiologists, NPs, PAs, and RNs review transmissions, sign reports, and coordinate care from any location. An on-call clinician who gets a weekend alert for new-onset AF or sustained VT can review the full transmission, start anticoagulation protocols, or escalate for device reprogramming from a smartphone. No one has to wait until Monday morning. This mobile capability extends the same 80% faster response time to clinicians working outside the clinic.
Schedule a demo to see Rhythm360's mobile dashboard and unified device compatibility in action.
Rhythm360 is vendor-neutral and works with pacemakers from all major OEMs, including Medtronic, Boston Scientific, Abbott, and Biotronik. The platform ingests data via direct API connections, HL7 feeds, XML files, and AI-powered computer vision for PDF-based reports, normalizing every format into one patient record. A practice with mixed-manufacturer devices does not need separate portal logins for each brand.
Rhythm360 captures the full ICD data set transmitted by OEM systems: shock history, ATP therapy logs, episode electrograms, lead impedance and sensing amplitude trends, ventricular arrhythmia burden, and device diagnostic summaries. Redundant data feeds keep transmissions flowing if an OEM server goes down. AI triage then prioritizes the most clinically significant alerts so staff act on urgent findings first.
Rhythm360 processes monthly ILR and ICM transmissions from devices like the Medtronic LINQ and Abbott Confirm Rx. It automatically quantifies AF burden, flags pause events, and correlates symptomatic episodes. For cryptogenic stroke follow-up, the platform auto-documents each qualifying transmission to support CPT 93299 billing, and AI prioritization speeds clinician review, which matters because covert AF detected by ILRs often drives anticoagulation decisions that prevent recurrent stroke.
Yes. Rhythm360 ingests daily CardioMEMS PA pressure and heart rate transmissions and displays them in the same dashboard as data from co-implanted CIEDs. Clinicians managing heart failure patients with both a CardioMEMS sensor and a CRT-D or ICD can review hemodynamic trends and rhythm data in one workflow instead of toggling between the Abbott CardioMEMS portal and a separate device system.
Rhythm360 automates documentation for the primary CIED remote monitoring CPT codes: 93298 for quarterly remote interrogation of ICDs and CRT devices, 93299 for monthly interrogation of ICDs, CRT devices, and implantable cardiac monitors, and 99454 for remote physiological monitoring device supply and transmission. The administrative dashboard shows in real time which patients have qualifying transmissions and which billable events remain uncaptured, cutting the revenue leakage caused by manual, fragmented workflows.
Every major cardiac device category, pacemakers, ICDs, CRT and CCM devices, implantable loop recorders, and CardioMEMS PA sensors, works with remote monitoring platforms in 2026. The real question is whether a practice manages those data streams through separate OEM portals or through one vendor-neutral platform that normalizes every transmission, automates CPT documentation, and triages alerts with AI.
Remote monitoring already covers a substantial share of eligible CIED patients, and guideline-based alert management cuts non-actionable alerts without raising the risk of adverse outcomes. Practices that invest in unified infrastructure now are positioned to capture the full clinical and financial value of that coverage, including the transmissibility, response time, and revenue gains outlined above.
